 
 
The Dangers of Statin Drugs: What You Haven't Been Told About
  Cholesterol-Lowering Medication, Part I
  
   
  [ Part I, Part II, Part III ]
   
  By Sally Fallon and Mary G. Enig, PhD
  Originally printed at Weston A. Price
   
  Hypercholesterolemia is the health issue of the 21st century. It is
  actually an invented disease, a "problem" that emerged when health
  professionals learned how to measure cholesterol levels in the blood.
  High cholesterol exhibits no outward signs--unlike other conditions of
  the blood, such as diabetes or anemia, diseases that manifest telltale
  symptoms like thirst or weakness--hypercholesterolemia requires the
  services of a physician to detect its presence. Many people who feel
  perfectly healthy suffer from high cholesterol--in fact, feeling good
  is actually a symptom of high cholesterol!
   
  Doctors who treat this new disease must first convince their patients
  that they are sick and need to take one or more expensive drugs for the
  rest of their lives, drugs that require regular checkups and blood
  tests. But such doctors do not work in a vacuum--their efforts to
  convert healthy people into patients are bolstered by the full weight
  of the U.S. government, the media and the medical establishment,
  agencies that have worked in concert to disseminate the cholesterol
  dogma and convince the population that high cholesterol is the
  forerunner of heart disease and possibly other diseases as well.
   
  Who suffers from hypercholesterolemia? Peruse the medical literature of
  25 or 30 years ago and you'll get the following answer: any middle-aged
  man whose cholesterol is over 240 with other risk factors, such as
  smoking or overweight.
   
  After the Cholesterol Consensus Conference in 1984, the parameters
  changed; anyone (male or female) with cholesterol over 200 could
  receive the dreaded diagnosis and a prescription for pills. Recently
  that number has been moved down to 180. If you have had a heart attack,
  you get to take cholesterol-lowering medicines even if your cholesterol
  is already very low--after all, you have committed the sin of having a
  heart attack so your cholesterol must therefore be too high. The
  penance is a lifetime of cholesterol-lowering medications along with a
  boring low-fat diet. But why wait until you have a heart attack? Since
  we all labor under the stigma of original sin, we are all candidates
  for treatment. Current edicts stipulate cholesterol testing and
  treatment for young adults and even children.
   
  The drugs that doctors use to treat the new disease are called
  statins--sold under a variety of names including:
   
  Lipitor (atorvastatin)
  Zocor (simvastatin)
  Mevacor (lovastatin)
  Pravachol (pravastatin)
  How Statins Work
   
  This diagram illustrates the pathways involved in cholesterol
  production.
   
  The process begins with acetyl-CoA, a two-carbon molecule sometimes
  referred to as the "building block of life." Three acetyl-CoA molecules
  combine to form six-carbon hydroxymethyl glutaric acid (HMG). The step
  from HMG to mevalonate requires an enzyme, HMG-CoA reductase. Statin
  drugs work by inhibiting this enzyme--hence the formal name of HMG-CoA
  reductase inhibitors. Herein lies the potential for numerous side
  effects, because statin drugs inhibit not just the production of
  cholesterol, but a whole family of intermediary substances, many if not
  all of which have important biochemical functions in their own right.
   
  Consider the findings of pediatricians at the University of California,
  San Diego who published a description of a child with a hereditary
  defect of mevalonic kinase, the enzyme that facilitates the next step
  beyond HMG-CoA reductase.1 The child was mentally retarded,
  microcephalic (very small head), small for his age, profoundly anemic,
  acidotic and febrile. He also had cataracts. Predictably, his
  cholesterol was consistently low--70-79 mg/dl. He died at the age of 24
  months. The child represents an extreme example of cholesterol
  inhibition, but his case illuminates the possible consequences of
  taking statins in strong doses or for a lengthy period of time:
   
  Depression of mental acuity
  Anemia
  Acidosis
  Frequent fevers
  Cataracts
  Cholesterol is one of three end products in the mevalonate chain. The
  two others are ubiquinone and dilochol. Ubiquinone or Co-Enzyme Q10 is
  a critical cellular nutrient biosynthesized in the mitochondria. It
  plays a role in ATP production in the cells and functions as an
  electron carrier to cytochrome oxidase, our main respiratory enzyme.
  The heart requires high levels of Co-Q10. A form of Co-Q10 called
  ubiquinone is found in all cell membranes where it plays a role in
  maintaining membrane integrity so critical to nerve conduction and
  muscle integrity. Co-Q10 is also vital to the formation of elastin and
  collagen. Side effects of Co-Q10 deficiency include muscle wasting
  leading to weakness and severe back pain, heart failure (the heart is a
  muscle!), neuropathy and inflammation of the tendons and ligaments,
  often leading to rupture.
   
  Dolichols also play a role of immense importance. In the cells they
  direct various proteins manufactured in response to DNA directives to
  their proper targets, ensuring that the cells respond correctly to
  genetically programmed instruction. Thus statin drugs can lead to
  unpredictable chaos on the cellular level, much like a computer virus
  that wipes out certain pathways or files.
   
  Squalene, the immediate precursor to cholesterol, has anti-cancer
  effects, according to research.
   
  The fact that some studies have shown that statins can prevent heart
  disease, at least in the short term, is most likely explained not by
  the inhibition of cholesterol production but because they block the
  creation of mevalonate. Reduced amounts of mevalonate seem to make
  smooth muscle cells less active, and platelets less able to produce
  thromboxane. Atherosclerosis begins with the growth of smooth muscle
  cells in side artery walls and thromboxane is necessary for blood
  clotting.
   
  Cholesterol
   
  Of course, statins inhibit the production of cholesterol--they do this
  very well. Nowhere is the failing of our medical system more evident
  than in the wholesale acceptance of cholesterol reduction as a way to
  prevent disease--have all these doctors forgotten what they learned in
  biochemistry 101 about the many roles of cholesterol in the human
  biochemistry?
   
  Every cell membrane in our body contains cholesterol because
  cholesterol is what makes our cells waterproof--without cholesterol we
  could not have a different biochemistry on the inside and the outside
  of the cell. When cholesterol levels are not adequate, the cell
  membrane becomes leaky or porous, a situation the body interprets as an
  emergency, releasing a flood of corticoid hormones that work by
  sequestering cholesterol from one part of the body and transporting it
  to areas where it is lacking. Cholesterol is the body's repair
  substance: scar tissue contains high levels of cholesterol, including
  scar tissue in the arteries.
   
  Cholesterol is the precursor to vitamin D, necessary for numerous
  biochemical processes including mineral metabolism. The bile salts,
  required for the digestion of fat, are made of cholesterol. Those who
  suffer from low cholesterol often have trouble digesting fats.
  Cholesterol also functions as a powerful antioxidant, thus protecting
  us against cancer and aging.
   
  Cholesterol is vital to proper neurological function. It plays a key
  role in the formation of memory and the uptake of hormones in the
  brain, including serotonin, the body's feel-good chemical. When
  cholesterol levels drop too low, the serotonin receptors cannot work.
  Cholesterol is the main organic molecule in the brain, constituting
  over half the dry weight of the cerebral cortex.
   
  Finally, cholesterol is the precursor to all the hormones produced in
  the adrenal cortex including glucocorticoids, which regulate blood
  sugar levels, and mineralocorticoids, which regulate mineral balance.
  Corticoids are the cholesterol-based adrenal hormones that the body
  uses in response to stress of various types; it promotes healing and
  balances the tendency to inflammation. The adrenal cortex also produces
  sex hormones, including testosterone, estrogen and progesterone, out of
  cholesterol. Thus, low cholesterol--whether due to an innate error of
  metabolism or induced by cholesterol-lowering diets and drugs--can be
  expected to disrupt the production of adrenal hormones and lead to:
   
  Blood sugar problems
  Edema
  Mineral deficiencies
  Chronic inflammation
  Difficulty in healing
  Allergies
  Asthma
  Reduced libido
  Infertility
  Various reproductive problems
  Enter the Statins
   
  Statin drugs entered the market with great promise. They replaced a
  class of pharmaceuticals that lowered cholesterol by preventing its
  absorption from the gut. These drugs often had immediate and unpleasant
  side effects, including nausea, indigestion and constipation, and in
  the typical patient they lowered cholesterol levels only slightly.
  Patient compliance was low: the benefit did not seem worth the side
  effects and the potential for use very limited. By contrast, statin
  drugs had no immediate side effects: they did not cause nausea or
  indigestion and they were consistently effective, often lowering
  cholesterol levels by 50 points or more.
   
  During the last 20 years, the industry has mounted an incredible
  promotional campaign--enlisting scientists, advertising agencies, the
  media and the medical profession in a blitz that turned the statins
  into one of the bestselling pharmaceuticals of all time. Sixteen
  million Americans now take Lipitor, the most popular statin, and drug
  company officials claim that 36 million Americans are candidates for
  statin drug therapy.
   
  What bedevils the industry is growing reports of side effects that
  manifest many months after the commencement of therapy; the November
  2003 issue of Smart Money magazine reports on a 1999 study at St.
  Thomas' Hospital in London (apparently unpublished), which found that
  36 percent of patients on Lipitor's highest dose reported side effects;
  even at the lowest dose, 10 percent reported side effects.2
   
  Muscle Pain and Weakness
   
  The most common side effect is muscle pain and weakness, a condition
  called rhabdomyolysis, most likely due to the depletion of Co-Q10, a
  nutrient that supports muscle function. Dr. Beatrice Golomb of San
  Diego, California is currently conducting a series of studies on statin
  side effects. The industry insists that only 2-3 percent of patients
  get muscle aches and cramps but in one study, Golomb found that 98
  percent of patients taking Lipitor and one-third of the patients taking
  Mevachor (a lower-dose statin) suffered from muscle problems.3 A
  message board devoted to Lipitor at forum.ditonline.com contains more
  than 800 posts, many detailing severe side effects. The Lipitor board
  at contains more than 2,600 posts.
   
  The test for muscle wasting or rhabdomyolysis is elevated levels of a
  chemical called creatine kinase (CK). But many people experience pain
  and fatigue even though they have normal CK levels.4
   
  Tahoe City resident Doug Peterson developed slurred speech, balance
  problems and severe fatigue after three years on Lipitor--for two and a
  half years, he had no side effects at all.5 It began with restless
  sleep patterns--twitching and flailing his arms. Loss of balance
  followed and the beginning of what Doug calls the "statin shuffle"--a
  slow, wobbly walk across the room. Fine motor skills suffered next. It
  took him five minutes to write four words, much of which was illegible.
  Cognitive function also declined. It was hard to convince his doctors
  that Lipitor could be the culprit, but when he finally stopped taking
  it, his coordination and memory improved.
   
  John Altrocchi took Mevacor for three years without side effects; then
  he developed calf pain so severe he could hardly walk. He also
  experienced episodes of temporary memory loss.
   
  For some, however, muscle problems show up shortly after treatment
  begins. Ed Ontiveros began having muscle problems within 30 days of
  taking Lipitor. He fell in the bathroom and had trouble getting up. The
  weakness subsided when he went off Lipitor. In another case, reported
  in the medical journal Heart, a patient developed rhabdomyolysis after
  a single dose of a statin.6 Heel pain from plantar fascitis (heel
  spurs) is another common complaint among those taking statin drugs. One
  correspondent reported the onset of pain in the feet shortly after
  beginning statin treatment. She had visited an evangelist, requesting
  that he pray for her sore feet. He enquired whether she was taking
  Lipitor. When she said yes, he told her that his feet had also hurt
  when he took Lipitor.7
   
  Active people are much more likely to develop problems from statin use
  than those who are sedentary. In a study carried out in Austria, only
  six out of 22 athletes with familial hypercholesterolemia were able to
  endure statin treatment.8 The others discontinued treatment because of
  muscle pain.
   
  By the way, other cholesterol-lowering agents besides statin drugs can
  cause joint pain and muscle weakness. A report in Southern Medical
  Journal described muscle pains and weakness in a man who took Chinese
  red rice, an herbal preparation that lowers cholesterol.9 Anyone
  suffering from myopathy, fibromyalgia, coordination problems and
  fatigue needs to look at low cholesterol plus Co-Q10 deficiency as a
  possible cause.
   
  Stay tuned for Part II in the next issue of the newsletter.
   
  References
   
  [ Part I, Part II, Part III ]
  Next >>
  Related Articles:
   
  The Truth About Cholesterol-Lowering Drugs (Statins), Cholesterol, and
  Health
   
  Crestor and Other Statins: Are They Really Worth the Risk?
   
  Half of Population Will be Taking Statins
   
  Statins - Is the Danger is the Dose?
   
  Return to Table of Contents #553